Journal article
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
- Abstract:
- Lmo2 is an oncogenic transcription factor that is frequently overexpressed in T-cell acute lymphoblastic leukemia (T-ALL), including early T-cell precursor ALL (ETP-ALL) cases with poor prognosis. Lmo2 must be recruited to DNA by binding to the hematopoietic basic helix-loop-helix factors Scl/Tal1 or Lyl1. However, it is unknown which of these factors can mediate the leukemic activity of Lmo2. To address this, we have generated Lmo2-transgenic mice lacking either Scl or Lyl1 in the thymus. We show that although Scl is dispensable for Lmo2-driven leukemia, Lyl1 is critical for all oncogenic functions of Lmo2, including upregulation of a stem cell-like gene signature, aberrant self-renewal of thymocytes, and subsequent generation of T-cell leukemia. Lyl1 expression is restricted to preleukemic and leukemic stem cell populations in this model, providing a molecular explanation for the stage-specific expression of the Lmo2-induced gene expression program. Moreover, LMO2 and LYL1 are coexpressed in ETP-ALL patient samples, and LYL1 is required for growth of ETP-ALL cell lines. Thus, the LMO2-LYL1 interaction is a promising therapeutic target for inhibiting self-renewing cancer stem cells in T-ALL, including poor-prognosis ETP-ALL cases.
Actions
Authors
- Journal:
- Blood More from this journal
- Volume:
- 122
- Issue:
- 12
- Pages:
- 2093-2103
- Publication date:
- 2013-09-01
- DOI:
- EISSN:
-
1528-0020
- ISSN:
-
0006-4971
- Language:
-
English
- Keywords:
-
- Pubs id:
-
pubs:441287
- UUID:
-
uuid:8f179684-3c5c-4f3b-9f0c-82a934e032e0
- Local pid:
-
pubs:441287
- Source identifiers:
-
441287
- Deposit date:
-
2014-09-10
Terms of use
- Copyright date:
- 2013
If you are the owner of this record, you can report an update to it here: Report update to this record